AKT1 and breast carcinoma: Studies also showed that miR-221/222 enhanced breast cancer growth, migration, and invasion, meanwhile propagating the self-renewal of breast cancer stem cells by targeting phosphatase and tensin homolog/Akt (PTEN/Akt) pathway (62).